Currently established and employed biomarkers of Alzheimer's disease (AD) predominantly
mirror AD-associated molecular and structural brain changes. While they are necessary for …

Electroencephalography (EEG) and related methodologies offer the promise of predicting
the likelihood that novel therapies and compounds will exhibit clinical efficacy early in …

EEG abnormalities have been reported for both dementia with Lewy bodies (DLB) and
Alzheimer's disease (AD). Although it has been suggested that variations in mean EEG …

OBJECTIVE: The present study tested the hypothesis that cortical electroencephalographic
(EEG) rhythms. change across normal elderly (Nold), mild cognitive impairment (MCI), and …

An extensive literature reports changes in quantitative electroencephalogram (QEEG) with
aging and a relationship between magnitude of changes and degree of clinical deterioration …

Based on the authors' groundbreaking research, Automated EEG-Based Diagnosis of
Neurological Disorders: Inventing the Future of Neurology presents a research ideology, a …

Mild cognitive impairment (MCI) as a precursor of dementia with Lewy bodies (DLB) is the
focus of recent research, trying to explore the early mechanisms and possible biomarkers of …

The present study investigates whether a combined cognitive and physical training may
induce changes in the cortical activity as measured via electroencephalogram (EEG) and …

Distinguishing between Alzheimer's disease (AD) and frontotemporal dementia (FTD)
presents a clinical challenge. Inexpensive and accessible techniques such as …

OBJECTIVE: To compare EEG power spectra and LORETA-computed intracortical activity
between Alzheimer's disease (AD) patients and healthy controls, and to correlate the results …